Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics
出版年份 2020 全文链接
标题
Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics
作者
关键词
-
出版物
Clinical & Translational Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-15
DOI
10.1007/s12094-020-02488-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers
- (2020) Juan Wang et al. Cell Communication and Signaling
- The renin–angiotensin system blockers and survival in digestive system malignancies
- (2020) Qi Zhou et al. MEDICINE
- Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin-receptor blockers and an increased risk of cancer
- (2019) Thomas Datzmann et al. European Journal of Internal Medicine
- The contamination of valsartan and other sartans, part 1: New findings
- (2019) Fritz Sörgel et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The clinical impact of angiotensin-(1–7)/mitochondrial assembly receptor axis in esophageal squamous cell carcinoma patients receiving curative esophagectomy
- (2019) Yen-Hao Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The (pro)renin receptor in health and disease
- (2019) Atsuhiro Ichihara et al. Nature Reviews Nephrology
- Angiotensin II‐induced micro RNA‐21 culprit for non‐small‐cell lung adenocarcinoma
- (2019) Zhaoji Luan et al. DRUG DEVELOPMENT RESEARCH
- Angiotensin‐converting enzyme gene polymorphism and digestive system cancer risk: A meta‐analysis based on 9656 subjects
- (2019) Hossein Abdeahad et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association between ACE A240T polymorphism and cancer risk: a meta-analysis
- (2019) Yingjun Xiao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Renin–angiotensin system gene polymorphisms and colorectal cancer risk: a meta-analysis
- (2019) Zhen Cheng et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Acetylation and Amination Protect Angiotensin 1–7 from Physiological Hydrolyzation and Therefore Increases Its Antitumor Effects on Lung Cancer
- (2018) Xiaowen Ma et al. MOLECULAR PHARMACEUTICS
- Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B
- (2018) Sameh Saber et al. TOXICOLOGY LETTERS
- Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway
- (2018) Suolin Zhang et al. Oncology Letters
- Angiotensin 1–7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer
- (2018) Kamila Domińska et al. Scientific Reports
- Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study
- (2018) Anton Pottegård et al. BMJ-British Medical Journal
- Pre-treatment with angiotensin-(1–7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts
- (2018) Yu-Tsai Lin et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
- (2018) Blánaid M Hicks et al. BMJ-British Medical Journal
- Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
- (2017) Nana Pei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Do renin–angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?
- (2017) Hong Sun et al. MEDICINE
- Expression of (Pro)renin Receptor During Rapamycin-Induced Erythropoiesis in K562 Erythroleukemia Cells and Its Possible Dual Actions on Erythropoiesis
- (2017) Kiriko Kaneko et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Interaction of renin–angiotensin system and adenosine monophosphate–activated protein kinase signaling pathway in renal carcinogenesis of uninephrectomized rats
- (2017) Ke-Ke Yang et al. TUMOR BIOLOGY
- Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells
- (2017) Nadia Cambados et al. Oncotarget
- The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
- (2017) Juanjuan Xu et al. Frontiers in Physiology
- Downregulation of ACE2/Ang-(1–7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry
- (2016) Changhui Yu et al. CANCER LETTERS
- Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line
- (2016) Elham Bakhtiari et al. JOURNAL OF CHEMOTHERAPY
- Renin-angiotensin system blockade for the risk of cancer and death
- (2016) J. Shen et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan
- (2016) Zhang Yue et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Support for involvement of the renin–angiotensin system in dysplastic Barrett’s esophagus
- (2016) Svein Olav Bratlie et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
- (2016) Yeqing Mao et al. Oncotarget
- Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis
- (2016) Arivajiagane Arundhathi et al. Oncotarget
- Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation
- (2016) Shau-Hsuan Li et al. Oncotarget
- Expression of renin–angiotensin system (RAS) components in endometrial cancer
- (2016) Sarah J Delforce et al. Endocrine Connections
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- MicroRNA Profiling of the Effect of the Heptapeptide Angiotensin-(1-7) in A549 Lung Tumor Cells Reveals a Role for miRNA149-3p in Cellular Migration Processes
- (2016) Brenda de Oliveira da Silva et al. PLoS One
- Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
- (2015) Yi-Ning Dai et al. CANCER CAUSES & CONTROL
- Expression of MAS1 in breast cancer
- (2015) Yi Luo et al. CANCER SCIENCE
- Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
- (2015) R. R. McKay et al. CLINICAL CANCER RESEARCH
- The relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: Insights from a meta-analysis
- (2015) Hualing Yang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB
- (2015) Venkatachalam Gopi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Ang II-AT1R Increases Cell Migration Through PI3K/AKT and NF-κB Pathways in Breast Cancer
- (2014) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation
- (2014) Li-xia Yang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Identification of renin progenitors in the mouse bone marrow that give rise to B-cell leukaemia
- (2014) Brian C. Belyea et al. Nature Communications
- LKB1 and AMPK and the cancer-metabolism link - ten years after
- (2013) D Hardie et al. BMC BIOLOGY
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin receptor blockers
- (2013) Gowtham Adamane Rao et al. JOURNAL OF HYPERTENSION
- AGT M235T variant is not associated with risk of cancer
- (2013) Jianjun Lin et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- Long-term use of angiotensin II receptor blockers and risk of cancer: A population-based cohort analysis
- (2012) Kang-Ling Wang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling
- (2012) Hong Ren ONCOLOGY REPORTS
- MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1
- (2012) Y. Dai et al. PLACENTA
- Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer
- (2012) Satoru Takahashi et al. PROSTATE
- Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk
- (2011) Ilke Sipahi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
- (2011) Chin-Chou Huang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation
- (2011) Cuneyt K. Buharalioglu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1
- (2011) C. Lu et al. BLOOD
- Association between polymorphisms of the renin–angiotensin system genes and breast cancer risk: a meta-analysis
- (2011) Bo Xi et al. BREAST CANCER RESEARCH AND TREATMENT
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
- (2011) Úna C. Mc Menamin et al. CANCER CAUSES & CONTROL
- Use of Angiotensin Receptor Blockers and the Risk of Cancer
- (2011) Björn Pasternak et al. CIRCULATION
- The ACE Insertion/Deletion Polymorphism and Risk of Cancer, a Review and Meta-Analysis of the Literature
- (2011) R. Ruiter et al. CURRENT CANCER DRUG TARGETS
- MicroRNAs and developmental timing
- (2011) Victor Ambros CURRENT OPINION IN GENETICS & DEVELOPMENT
- Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
- (2011) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma
- (2011) Stella Bernardi et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
- (2010) Jaclyn H Neo et al. BMC CANCER
- Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
- (2010) Chiyo Doi et al. BMC CANCER
- Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
- (2010) Lara Pickel et al. CANCER BIOLOGY & THERAPY
- Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
- (2010) K. L. Cook et al. CANCER RESEARCH
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells
- (2010) Qiaoke Gong et al. PANCREAS
- An ATIPical family of angiotensin II AT2 receptor-interacting proteins
- (2010) Sylvie Rodrigues-Ferreira et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C
- (2009) P. Gandellini et al. CANCER RESEARCH
- A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
- (2009) Xiaojun Liu et al. CIRCULATION RESEARCH
- Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
- (2009) Kashif Hanif et al. HYPERTENSION RESEARCH
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells
- (2009) Navdeep Chehl et al. JOURNAL OF GASTROINTESTINAL SURGERY
- 8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis
- (2009) Sylvie Rodrigues-Ferreira et al. PLoS One
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
- (2009) M. Seike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The renin-angiotensin system and malignancy
- (2008) E. I. Ager et al. CARCINOGENESIS
- Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
- (2008) Silvia De la Iglesia Iñigo et al. LEUKEMIA RESEARCH
- Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
- (2008) Yujun George Zheng et al. MEDICINAL RESEARCH REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started